Did you miss the TESTING reboot discussion? No worries, we have you covered here:

Welcome to #TenTweetNephJC where we will be discussing the largest randomized, placebo controlled trial of steroid treatment in IgA nephropathy patients.
✳️ 10 tweets #NephJC catch-up ✳️ pic.twitter.com/kRdt91F8gq
— Nephrology Jrnl Club (@NephJC) June 21, 2022